 "Vaccine")
Moderna’s Chief Executive Officer Stephane Bancel expects interim results from its Covid-19 vaccine trial in November, and if all goes well, said the US government could give an emergency use nod in December, the Wall Street Journal reported on Monday.
Speaking at the newspaper's annual Tech Live conference, Bancel also said sufficient interim results from the study takes longer to get and that the government's permission to use the vaccine may not come until next year.
The first interim analysis of the vaccine's efficacy will happen when 53 people in the entire study get symptomatic Covid-19, the report said.
“That first
